Real-time enrollment status for this systemic lupus erythematosus (sle) clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:09 AM UTC
| NCT Number | NCT06032923 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus (Sle) |
| Phase | PHASE1 |
| Target Enrollment | 78 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 20, 2026: Clinical trial NCT06032923 is currently recruiting participants. This phase1 study for systemic lupus erythematosus (sle) is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06032923 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06032923 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.